Correlation Between Qingdao Haier and China Asset

Can any of the company-specific risk be diversified away by investing in both Qingdao Haier and China Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qingdao Haier and China Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qingdao Haier Biomedical and China Asset Management, you can compare the effects of market volatilities on Qingdao Haier and China Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qingdao Haier with a short position of China Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qingdao Haier and China Asset.

Diversification Opportunities for Qingdao Haier and China Asset

0.44

Correlation Coefficient

Qingdao Haier  China Asset

Very weak diversification

The 3 months correlation between Qingdao and China is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Qingdao Haier Biomedical and China Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Asset Management and Qingdao Haier is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qingdao Haier Biomedical are associated (or correlated) with China Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Asset Management has no effect on the direction of Qingdao Haier i.e., Qingdao Haier and China Asset go up and down completely randomly.

Pair Corralation between Qingdao Haier and China Asset

Assuming the 90 days trading horizon Qingdao Haier Biomedical is expected to under-perform the China Asset. In addition to that, Qingdao Haier is 3.34 times more volatile than China Asset Management. It trades about -0.14 of its total potential returns per unit of risk. China Asset Management is currently generating about 0.45 per unit of volatility. If you would invest  341.00  in China Asset Management on October 11, 2024 and sell it today you would earn a total of  29.00  from holding China Asset Management or generate 8.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Qingdao Haier Biomedical  vs.  China Asset Management

Qingdao Haier Biomedical

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao Haier Biomedical are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Qingdao Haier is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

China Asset Management

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in China Asset Management are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Asset sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Qingdao Haier and China Asset

The main advantage of trading using opposite Qingdao Haier and China Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qingdao Haier position performs unexpectedly, China Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Asset will offset losses from the drop in China Asset's long position.

The idea behind Qingdao Haier Biomedical and China Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.